CYB5A
Basic information
Region (hg38): 18:74250846-74291973
Previous symbols: [ "CYB5" ]
Links
Phenotypes
GenCC
Source:
- 46,XY disorder of sex development due to isolated 17,20-lyase deficiency (Supportive), mode of inheritance: AR
- methemoglobinemia type 4 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methemoglobinemia and ambiguous genitalia | AR | Endocrine; Oncologic; Genitourinary | Hormonal treatment (eg, with estrogen or testosterone) may be beneficial related to sexual characteristics; Due to risk of gonadal tumors, surgical removal may be indicated | Endocrine; Hematologic; Oncologic; Genitourinary | 3951505; 8168836; 22170710 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYB5A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 4 | |||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 2 | 2 | 2 | 4 |
Variants in CYB5A
This is a list of pathogenic ClinVar variants found in the CYB5A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-74260915-C-T | Benign (Jan 25, 2024) | |||
18-74260927-T-C | Likely benign (Jan 08, 2019) | |||
18-74260963-G-C | Benign (Jun 30, 2023) | |||
18-74263351-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
18-74263366-T-C | not specified | Uncertain significance (Mar 03, 2022) | ||
18-74263476-T-A | Methemoglobinemia type 4 | Likely pathogenic (Oct 15, 2018) | ||
18-74263479-T-C | Methemoglobinemia type 4 | Pathogenic (Mar 20, 1986) | ||
18-74263486-A-G | CYB5A-related disorder | Likely benign (Aug 22, 2024) | ||
18-74263490-G-T | Benign (Jan 24, 2024) | |||
18-74291736-C-A | Benign (Jan 24, 2024) | |||
18-74291795-C-T | Methemoglobinemia type 4 | Likely pathogenic (Oct 15, 2018) | ||
18-74291797-A-C | not specified | Uncertain significance (Aug 10, 2024) | ||
18-74291840-G-A | Benign (Jan 25, 2024) | |||
18-74291851-C-A | CYB5A-related disorder | Likely benign (Oct 23, 2018) | ||
18-74291863-A-C | not specified | Conflicting classifications of pathogenicity (Dec 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYB5A | protein_coding | protein_coding | ENST00000340533 | 5 | 38722 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00158 | 0.707 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0855 | 76 | 73.9 | 1.03 | 0.00000381 | 892 |
Missense in Polyphen | 24 | 20.914 | 1.1476 | 274 | ||
Synonymous | -1.60 | 37 | 26.5 | 1.40 | 0.00000146 | 236 |
Loss of Function | 0.784 | 5 | 7.28 | 0.687 | 3.11e-7 | 90 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cytochrome b5 is a membrane bound hemoprotein which function as an electron carrier for several membrane bound oxygenases.;
- Disease
- DISEASE: Methemoglobinemia and ambiguous genitalia (METAG) [MIM:250790]: An autosomal recessive disorder characterized by sex steroid deficiency but normal glucocorticoid and mineralocorticoid reserve, male undermasculinization, absent or disturbed pubertal development, decreased levels of erythrocyte cytochrome B5, and excessive amounts of methemoglobin in blood cells resulting in cyanosis and hypoxia. {ECO:0000269|PubMed:20080843, ECO:0000269|PubMed:22170710, ECO:0000269|PubMed:8168836}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Methylene Blue Pathway, Pharmacodynamics;Oxidation by Cytochrome P450;Vitamin C (ascorbate) metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.335
Intolerance Scores
- loftool
- 0.354
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 59.76
Haploinsufficiency Scores
- pHI
- 0.185
- hipred
- Y
- hipred_score
- 0.572
- ghis
- 0.440
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.854
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyb5a
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- L-ascorbic acid metabolic process;electron transport chain;response to cadmium ion;proton transmembrane transport
- Cellular component
- mitochondrial outer membrane;endoplasmic reticulum membrane;cytosol;membrane;integral component of membrane;intracellular membrane-bounded organelle
- Molecular function
- aldo-keto reductase (NADP) activity;cytochrome-c oxidase activity;enzyme binding;heme binding;metal ion binding